Tα1 · 28-Amino Acid Thymic Immunomodulator
28-amino acid thymic peptide. Clinically studied in immunodeficiency, hepatitis B/C, and cancer adjuvant research. Dendritic cell activator.
Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide originally isolated from thymic fraction 5. It is the most clinically advanced thymic peptide, approved in 37 countries (as Zadaxin). Research documents dendritic cell maturation, Th1 immune pathway activation, NK cell enhancement, and antiviral activity. Used in COVID-19, hepatitis, and oncology research contexts.
Store lyophilized at -20°C. Reconstitute in bacteriostatic water. Use within 4 weeks at 2–8°C. Stable peptide — good shelf life when dry.